During the past decade, New Generation of Medical Research conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Generation of Medical Research" #1 sponsor was "NewAmsterdam Pharma" with 2 trials, followed by "Akebia Therapeutics" with 1 trials sponsored, "Allena Pharmaceuticals" with 1 trials sponsored, "Applied Therapeutics, Inc." with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Generation of Medical Research" #1 collaborator was "Cyclerion Therapeutics" with 1 trials as a collaborator and "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "New Generation of Medical Research" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Chronic Kidney Diseases" (2 trials), "Heart Failure With Preserved Ejection Fraction" (2 trials), "Chronic Heart Failure With Reduced Ejection Fraction" (1 trials) and "Diabetic Cardiomyopathies" (1 trials). Many other conditions were trialed in "New Generation of Medical Research" in a lesser frequency.

Most popular intervention types in "New Generation of Medical Research" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Obicetrapib" (2 trials), "ALLN-346" (1 trials), "AT-001" (1 trials) and "Cilofexor (CILO)/Firsocostat (FIR)" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Generation of Medical Research" are 10 trials for "All" genders.

Currently, there are NaN active trials in "New Generation of Medical Research". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in New Generation of Medical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in New Generation of Medical Research, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".